119 related articles for article (PubMed ID: 16828803)
1. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.
Guastella AJ; Dadds MR; Lovibond PF; Mitchell P; Richardson R
J Psychiatr Res; 2007 Sep; 41(6):466-71. PubMed ID: 16828803
[TBL] [Abstract][Full Text] [Related]
2. D-cycloserine-augmented one-session treatment of specific phobias in children and adolescents.
Farrell LJ; Waters AM; Oar EL; Tiralongo E; Garbharran V; Alston-Knox C; McConnell H; Collings N; Zimmer-Gembeck M; Donovan CL; Testa C; Storch EA; Ollendick TH
Brain Behav; 2018 Jun; 8(6):e00984. PubMed ID: 30106248
[TBL] [Abstract][Full Text] [Related]
3. A high-throughput clinical assay for testing drug facilitation of exposure therapy.
Rodebaugh TL; Levinson CA; Lenze EJ
Depress Anxiety; 2013 Jul; 30(7):631-7. PubMed ID: 23283838
[TBL] [Abstract][Full Text] [Related]
4. Augmenting extinction learning with D-cycloserine reduces return of fear: a randomized, placebo-controlled fMRI study.
Ebrahimi C; Gechter J; Lueken U; Schlagenhauf F; Wittchen HU; Hamm AO; Ströhle A
Neuropsychopharmacology; 2020 Feb; 45(3):499-506. PubMed ID: 31634897
[TBL] [Abstract][Full Text] [Related]
5. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis.
Rosenfield D; Smits JAJ; Hofmann SG; Mataix-Cols D; de la Cruz LF; Andersson E; Rück C; Monzani B; Pérez-Vigil A; Frumento P; Davis M; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner CA; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P; Turner C; Otto MW
J Anxiety Disord; 2019 Dec; 68():102149. PubMed ID: 31698111
[TBL] [Abstract][Full Text] [Related]
6. D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation.
Santa Ana EJ; Rounsaville BJ; Frankforter TL; Nich C; Babuscio T; Poling J; Gonsai K; Hill KP; Carroll KM
Drug Alcohol Depend; 2009 Oct; 104(3):220-7. PubMed ID: 19592176
[TBL] [Abstract][Full Text] [Related]
7. Using pre-treatment de novo threat conditioning outcomes to predict treatment response to DCS augmentation of exposure-based CBT.
Lubin RE; Fitzgerald HE; Rosenfield D; Carpenter JK; Papini S; Dutcher CD; Dowd SM; Hofmann SG; Pollack MH; Smits JAJ; Otto MW
J Psychiatr Res; 2023 Aug; 164():357-363. PubMed ID: 37399757
[TBL] [Abstract][Full Text] [Related]
8. Sleep promotes consolidation and generalization of extinction learning in simulated exposure therapy for spider fear.
Pace-Schott EF; Verga PW; Bennett TS; Spencer RM
J Psychiatr Res; 2012 Aug; 46(8):1036-44. PubMed ID: 22578824
[TBL] [Abstract][Full Text] [Related]
9. d-Cycloserine enhances durability of social skills training in autism spectrum disorder.
Wink LK; Minshawi NF; Shaffer RC; Plawecki MH; Posey DJ; Horn PS; Adams R; Pedapati EV; Schaefer TL; McDougle CJ; Swiezy NB; Erickson CA
Mol Autism; 2017; 8():2. PubMed ID: 28138381
[TBL] [Abstract][Full Text] [Related]
10. Examining the efficacy of d-cycloserine to augment therapeutic learning in depression.
Otto MW; Lee J; Hofmann SG; Hearon BA; Smits JA; Rosenfield D; Fava M; Wright JH
Contemp Clin Trials; 2016 May; 48():146-52. PubMed ID: 27094721
[TBL] [Abstract][Full Text] [Related]
11. Sleep quality and outcome of exposure therapy in adults with social anxiety disorder.
Dutcher CD; Dowd SM; Zalta AK; Taylor DJ; Rosenfield D; Perrone A; Otto MW; Pollack MH; Hofmann SG; Smits JAJ
Depress Anxiety; 2021 Nov; 38(11):1182-1190. PubMed ID: 34010494
[TBL] [Abstract][Full Text] [Related]
12. Enhancing panic and smoking reduction treatment with d-cycloserine: Study protocol for a randomized controlled trial.
Smits JA; Kauffman BY; Lee-Furman E; Zvolensky MJ; Otto MW; Piper ME; Powers MB; Rosenfield D
Contemp Clin Trials; 2016 May; 48():46-51. PubMed ID: 27015966
[TBL] [Abstract][Full Text] [Related]
13. A spiderless arachnophobia therapy: comparison between placebo and treatment groups and six-month follow-up study.
Granado LC; Ranvaud R; Peláez JR
Neural Plast; 2007; 2007():10241. PubMed ID: 17713595
[TBL] [Abstract][Full Text] [Related]
14. Generalization of beneficial exposure effects to untreated stimuli from another fear category.
Kodzaga I; Dere E; Zlomuzica A
Transl Psychiatry; 2023 Dec; 13(1):401. PubMed ID: 38114494
[TBL] [Abstract][Full Text] [Related]
15. Singular and combined effects of transcranial infrared laser stimulation and exposure therapy: A randomized clinical trial.
Zaizar ED; Gonzalez-Lima F; Telch MJ
Contemp Clin Trials; 2018 Sep; 72():95-102. PubMed ID: 30092284
[TBL] [Abstract][Full Text] [Related]
16. D-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders.
Hofmann SG; Wu JQ; Boettcher H
Biol Mood Anxiety Disord; 2013 Jun; 3(1):11. PubMed ID: 23768232
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.
Singewald N; Schmuckermair C; Whittle N; Holmes A; Ressler KJ
Pharmacol Ther; 2015 May; 149():150-90. PubMed ID: 25550231
[TBL] [Abstract][Full Text] [Related]
18. Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis.
Rodrigues H; Figueira I; Lopes A; Gonçalves R; Mendlowicz MV; Coutinho ES; Ventura P
PLoS One; 2014; 9(7):e93519. PubMed ID: 24991926
[TBL] [Abstract][Full Text] [Related]
19. D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions.
Smits JA; Rosenfield D; Otto MW; Marques L; Davis ML; Meuret AE; Simon NM; Pollack MH; Hofmann SG
J Psychiatr Res; 2013 Oct; 47(10):1455-61. PubMed ID: 23870811
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder.
Guastella AJ; Richardson R; Lovibond PF; Rapee RM; Gaston JE; Mitchell P; Dadds MR
Biol Psychiatry; 2008 Mar; 63(6):544-9. PubMed ID: 18179785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
